loader
Please Wait
Applying Filters...

EuroAPI Header EuroAPI Header

X

Technical details about Angiotensin (1-7), learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 51833-78-4, Angiotensin 1-7, Asp-arg-val-tyr-ile-his-pro, Txa127, Angiotensin i (1-7), Angiotensin-(1-7)
Molecular Formula
C41H62N12O11
Molecular Weight
899.0  g/mol
InChI Key
PVHLMTREZMEJCG-GDTLVBQBSA-N

Therapeutic Angiotensin-(1-7) is a synthetic heptapeptide identical to endogenous angiotensin-(1-7) with vasodilator and antiproliferative activities. Therapeutic angiotensin 1-7 may inhibit cyclooxygenase 2 (COX-2) and the production of proinflammatory prostaglandins and may activate the angiotensin-(1-7) receptor Mas, resulting in diminished tumor cell proliferation. Activation of the angiotensin-(1-7) receptor Mas, a G-protein coupled, seven transmembrane protein, may down-regulate the phosphorylation and activation of Erk1 and Erk2 in the Erk1/Erk2 MAPK signaling pathway. In the renin-angiotensin system, the vasodilating activity of angiotensin- (1-7), hydrolysed from angiotensin II by the type I transmembrane metallopeptidase and carboxypeptidase angiotensin converting enzyme 2 (ACE2) in vivo, counteracts the vasoconstricting activity of angiotensin II.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-1-[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic acid
2.1.2 InChI
InChI=1S/C41H62N12O11/c1-5-22(4)33(38(61)50-29(17-24-19-45-20-47-24)39(62)53-15-7-9-30(53)40(63)64)52-36(59)28(16-23-10-12-25(54)13-11-23)49-37(60)32(21(2)3)51-35(58)27(8-6-14-46-41(43)44)48-34(57)26(42)18-31(55)56/h10-13,19-22,26-30,32-33,54H,5-9,14-18,42H2,1-4H3,(H,45,47)(H,48,57)(H,49,60)(H,50,61)(H,51,58)(H,52,59)(H,55,56)(H,63,64)(H4,43,44,46)/t22-,26-,27-,28-,29-,30-,32-,33-/m0/s1
2.1.3 InChI Key
PVHLMTREZMEJCG-GDTLVBQBSA-N
2.1.4 Canonical SMILES
CCC(C)C(C(=O)NC(CC1=CN=CN1)C(=O)N2CCCC2C(=O)O)NC(=O)C(CC3=CC=C(C=C3)O)NC(=O)C(C(C)C)NC(=O)C(CCCN=C(N)N)NC(=O)C(CC(=O)O)N
2.1.5 Isomeric SMILES
CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@H]2C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Ang I (1-7)

2. Angiotensin 1-7

3. Angiotensin I (1-7)

4. Angiotensin Ii (1-7)

5. Angiotensin Ii (1-7) Heptapeptide

6. Angiotensin Ii-(1-7)

7. Angiotensin-(1-7)

8. Angiotensin-i (1-7)

9. Txa-127

10. Txa127

2.2.2 Depositor-Supplied Synonyms

1. 51833-78-4

2. Angiotensin 1-7

3. Asp-arg-val-tyr-ile-his-pro

4. Txa127

5. Angiotensin I (1-7)

6. Angiotensin-(1-7)

7. Angiotensin Ii (1-7) Heptapeptide

8. Angiotensin Ii (1-7)

9. 8-des-phe-angiotensin Ii

10. Ang-(1-7)

11. Txa-127

12. 39386-80-6

13. Angiotensin I/ii (1-7)

14. Chebi:55438

15. Ile(5)-angiotensin Ii (1-7)

16. L-alpha-aspartyl-l-arginyl-l-valyl-l-tyrosyl-l-isoleucyl-l-histidyl-l-proline

17. L-aspartyl-l-arginyl-l-valyl-l-tyrosyl-l-isoleucyl-l-histidyl-l-proline

18. (2s)-1-[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-carboxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]pyrrolidine-2-carboxylic Acid

19. Unii-ij3fuk8mof

20. Angiotensin, Canine, Rat

21. Human Angiotensin-(1-7)

22. 1-7-human Angiotensin Ii

23. Angiotensin Ii, Des-phe(8)-

24. Txa 127

25. Ang-1-7 Acetate

26. Angiotensin(1-7)

27. Mfcd00153513

28. Sh-heptapeptide-13

29. Angiotensini(1-7)

30. Bf-angiotensin 1-7

31. Angiotensin Ii, Des-phenylalanine(8)-

32. Ij3fuk8mof

33. Angiotensin, Canine, Ra

34. Angiotensin I/ii(1-7)

35. Ang 1-7

36. Angiotensin Fragment 1-7

37. 5-ile-angiotensin-(1-7)

38. Angiotensin Peptide (1-7)

39. Gtpl582

40. Ang(1-7)

41. Human Angiotensin Ii (1-7)

42. Angiotensin Ii, 5-l-isoleucine-8-de-l-phenylalanine-

43. Gtpl5578

44. [ile5]angiotensin I (1-7)

45. Angiotensin 1-7 Acetate

46. Chembl3545347

47. Schembl15926158

48. Bdbm85556

49. [125i]ang-(1-7)

50. Txa127; Ang-(1-7)

51. Zinc96077632

52. Akos024456667

53. Cs-3413

54. Db11720

55. Angiotensin Ii, 8-de-l-phenylalanine-

56. Ncgc00167219-01

57. As-76407

58. Hy-12403

59. [125i]angiotensin-(1-7) (human, Mouse, Rat)

60. 833a784

61. A901408

62. Angiotensin I/ii Fragment 1-7 Trifluoroacetate Salt

63. Q27074464

64. Aspartyl-argininyl-valinyl-tyrosinyl-isoleucinyl-histidinyl-proline;angiotensin 1-7

65. (2s)-1-[(2s)-2-[[(2s,3s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-hydroxy-4-oxobutanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanoyl]amino]-3-(3h-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic Acid

66. (s)-1-((6s,9s,12s,15s,18s)-18-((1h-imidazol-4-yl)methyl)-1-amino-6-((s)-2-amino-3-carboxypropanamido)-15-sec-butyl-12-(4-hydroxybenzyl)-1-imino-9-isopropyl-7,10,13,16-tetraoxo-2,8,11,14,17-pentaazanonadecane)pyrrolidine-2-carboxylic Acid

2.3 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 899.0 g/mol
Molecular Formula C41H62N12O11
XLogP3-3
Hydrogen Bond Donor Count12
Hydrogen Bond Acceptor Count14
Rotatable Bond Count25
Exact Mass898.46610084 g/mol
Monoisotopic Mass898.46610084 g/mol
Topological Polar Surface Area380 Ų
Heavy Atom Count64
Formal Charge0
Complexity1660
Isotope Atom Count0
Defined Atom Stereocenter Count8
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)


Vasodilator Agents

Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)


Post Enquiry
POST ENQUIRY